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mRNAs related to coagulant factors (FGB, F5, F8 and F13) was
obviously elevated (P<0.05) in patients with CAD, and the expres-
sion of 2 mRNAs (F5 and F8) among 14 genes was signiﬁcantly up-
regulated (P<0.01) in the AMI groups. (2) In AMI group, the
expression of all mRNAs related to anticoagulant factors was higher
than SAP and control groups, especially, the expression of 3
mRNA(TFPI THBD and SERPINA1) among 8 gens was signiﬁcantly
up-regulated (P<0.01). (3) Compared with control group, the
expression of 3 ﬁbrolysis factor-related mRNAs (SERPINE1 PLAU
and PLAUR) was signiﬁcantly up-regulated (P<0.01) in both groups
AMI and SAP. PLAT mRNA expression was not obviously elevated
and PLG mRNA expression was down-regulated in AMI and SAP
groups.
CONCLUSIONS In this study, there were imbalances in the expression
of mRNAs among coagulation, anticoagulation and ﬁbrinolysis: the
expression of many mRNAs related to coagulant factors and antico-
agulant factors was signiﬁcantly up-regulated, and the expression of
mRNAs related to ﬁbrinolytic system was disordered.
This disequilibrium plays an important role in the progression of
coronary artery disease and arterial thrombosis.GW26-e1456
The Clinical Characteristics, Treatment Status and Their Relations to
Prognosis among Patients Admitted to Tertiary A TCM hospital for Acute
Myocardial Infarction
Xin Hu, Hongxu Liu
Beijing Hospital of Traditional Chinese Medicine, Capital Medical
University
OBJECTIVES To improve clinical quality and patient outcomes in
tertiary A TCM hospitals by providing evidence-base ﬁndings which
obtained through investigation done on patients’ characteristics,
treatments status and prognosis among patients admitted for AMI
during 2013.
METHODS This research is done through analysis of all AMI in-patient
medical records sampled from 29 participated TCM hospitals based on
the diagnosis and treatments guideline for MI issued by Chinese
Medical Association. Cases data were obtain through standardized
CRF that looks into patients’ clinical characteristics, treatment and
prognosis. Data were managed with Microsoft SQL Server. We adopted
descriptive analysis method on general information with SPSS 15.0,
while logistic regression method was employed to conduct multi-
plicity analysis on their related prognosis. Statistical signiﬁcant was
deﬁned as P0.05.
RESULTS Total of 1217 AMI patients were reported to be admitted by
the 29 hospitals which agreed to participate in this research from 1st,
Jan to 31st Dec, 2013. Mean age of the sampled patients was
65.4812.96 years old, among which, 52.42% were over 65 years old,
357(29.55%) were female. 402 patients (34.04%) has been smoking
regularly while 225 (19.50%) has been regular drinker; 61.16%,
32.00% and 34.63% were reported to be associated with HTN, DM
and hyperlipidemia respectively. 439 patients (37.91%) had historical
diagnosis of CHD, 136(12.18%) had MI; 218 patients (18.59%) had
CVD. Meanwhile, 686 cases (59.04%) of STEMI patients were found
among all studied patients; 291 cases (24.87%) were diagnosed with
arrhythmias on admission. The rate of patients with in-hospital
Killip classiﬁcation I, II, III, IV was 54.15%, 23.50%, 8.79%, 7.97%
separately. The most frequently occurred TCM syndromes type of
deﬁcient were: heart-QI deﬁciency (62.37%), heart-YIN deﬁciency
(19.15%), spleen& kidney-QI deﬁciency (10.19%). 1053(86.52%) cases
showed symptoms of blood stasis, while 606 (49.80%) showed
characteristics of phlegm and retained ﬂuid. 536(44.04%) patients
underwent early reperfusion treatments. 1101 (90.47%) and 530
(43.55%) of all cases had received Chinese patent drug intravenously
and orally, 741(60.89%) patients had been given TCM decoction
subscriptions. After eliminated interactions effects, our ﬁnding in-
dicates the following factors has signiﬁcant inﬂuences on the death
rate of studied AMI patients: age, history of diabetes, arrhythmia,
Killip classiﬁcation, TCM clinical manifestations of spleen & kidney-
QI deﬁciency or cold coagulation, early revascularization, oral
Chinese patent drug and TCM decoction.
CONCLUSIONS Findings suggested that the risk factors of in-hospital
mortality including: age65 years, previous medical history of dia-
betes or arrhythmia, Killip classiﬁcationI, TCM clinical manifesta-
tions of spleen& kidney-QI deﬁciency or cold coagulation. Meanwhile,
early reperfusion, oral Chinese patent drug and decoction may have
positively improved short-term prognosis of AMI patients.GW26-e2511
The Correlation Analysis between plasma Cystatin C and the prognosis of
patients with STEMI
Pei Sun, Zhuqin Li
Department of Cardiology, The First Afﬁliated Hospital of Harbin
Medical University, Harbin, China
OBJECTIVES In recent years, the mortality of acute ST segment
Elevation Myocardial Infarction (STEMI) has been increased. Early
assessment for prognosis of STEMI patients is very signiﬁcant.
Although there already have some clinical marker for predicting the
prognosis of STEMI, it’s still dissatisﬁed. Preliminary research showed
that Cystatin C (Cys-C) has the independent prediction value for
STEMI. It seems to be that Cys-C might be involved in atherosclerotic
processes. Another study show that Cys-C and its fragments may also
affect the phagocytic and chemotactic ability of neutrophil, partici-
pates in the inﬂammatory process and regulates inﬂammatory re-
sponses. This study aims to analysis the correlation between plasma
Cys-C and the MACE in STEMI patients.
METHODS Hospitalized patients in coronary care unit of the First
Afﬁliated Hospital of Harbin Medical University from January 2012 to
December 2013 are selected. Patients were diagnosed as STEMI. A total
of 445 patients are selected. Observation indicator is the major adverse
cardiovascular events (MACE) occurrence of those patients in-hospital
and out-hospital. Patients are divided MACE group and non- MACE
group. Statistical analysis is performed. ROC curves of Cys-C, hsCRP,
TnI andCKMBare respectively drawn. Thepredictory value ferMACEas
well as to determine the threshold value. According to the concentra-
tion of plasmaCys-C, patients are divided high concentration group and
low concentration group, and respectively statistical analysis for two
group patients, thus evaluating the correlation among plasma Cys-C
level, the prognosis and adverse events of patients with STEMI.
RESULTS 1. The single factor analysis shows that the average value of
Cys-C in the MACE group is 1.09  0.23 mg/L, while in the non-MACE
group it is 0.82  0.15 mg/L, and there is statistical difference between
two groups (P < 0.0001).
2. Multiple factors analysis shows that OR value of Cys-C is 9.710,
95% CI (5.971, 5.971), indicating that Cys-C is an independent risk
factor of AMI.
3. The area under ROC curve of Cys-C is 0.8431, higher than that of
Hs-CRP (0.6249), TNI (0.544) and CK-MB (0.5569). The best cutoff
values that Cys - C predicting the MACE in STEMI patients is 0.94 mg/
L, the sensitivity was 77.14%, speciﬁcity of 80.85%.
4. With terms in-hospital stay, out-hospital in 1w 6 months and in 7
w12 months, in comparison, the incidence of MACE for the higher
concentration group are 57%, 31.64% and 48.57%, and the lower group
are 17.96%, 2.49% and 7.08% separately, P<0.05; and for terms in-
hospital stay, out-hospital within 1 w 6 months and within 7 w12
months, the total mortality of higher concentration group is 11.5%,
30% and 48.5%, and the lower concentration group, 1.63%, 2.04% and
8.89% separately, P<0.05.
CONCLUSIONS There might be some correlation between the Cys-C
and the MACE in STEMI patients. Cys-C is an independent risk factor
and potential prognosis indicator for MACE that happens both in-
hospital and out-hospital in STEMI patients.
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Mean Platelet Volume is the Predictor of Poor Myocardial Perfusion post
Primary PCI
Jianqiang Xu, Xiangdong Zhao, Chengzhi Lu
Tianjin 1st Central Hospital
OBJECTIVES Mean platelet volume (MPV) is shown to be the pre-
dictor of poor clinical outcome, as well as poor TIMI ﬂow in patients
receiving primary percutaneous coronary intervention (PPCI). But the
correlation of MPV and myocardial perfusion has not been well
demonstrated. So the aim of our study was to investigate the rela-
tionship between pre-intervention MPV and myocardial perfusion
post PPCI in patient with acute ST-segment elevation myocardial
infarction (STEMI).
METHODS Total of 168 consecutive patients from 2012, January to
2014, December suffered from STEMI undergoing PPCI were analyzed
retrospectively. The inclusion criteria were (1) age>65yrs; (2) PPCI was
performed within 12 hours from symptom onset; (3) the infarct-related
artery (IRA) was totally occluded; and (4) post intervention ﬂow was
TIMI 2 or greater. Exclusion criteria were (1) post history of myocardial
infarction, CABG or PCI of IRA; (2) presentation with shock or cardiac
arrest; (3) TIMI 1 or greater ﬂow at IRA at initial angiography; and
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perfusion was evaluated by myocardial perfusion grade (MBG). All the
patients were divided into good perfusion group (MBG 2, n¼137) and
poor perfusion group (MBG 1, n¼31) according to post intervention
MBG. The MPV, white blood cell (WBC) count, and so on were
compared. And the correlative factors were analyzed to ﬁnd out the
predictors of myocardial perfusion post PPCI.
RESULTS The MPV (11.21.4 fL vs. 9.51.3 fL, P <0.001) and WBC
count (11.11.0 109/L vs. 10.11.3 109/L, P <0.001) were higher in
poor perfusion group comparing with the good perfusion group.
Multivariate logistic regression analysis showed that MPV (OR 0.42,
95% CI 0.28-0.61, P <0.001) and WBC count (OR 0.59, 95% CI 0.39-
0.90, P ¼0.015) were the predictors of poor myocardial perfusion after
PPCI. MPV was also correlated with post PPCI MBG (r ¼ -0.607,
P<0.001) and LVEF (r ¼ -0.621, P <0.001).
CONCLUSIONS In STEMI patient receiving PPCI, higher pre-inter-
vention MPV and WBC count means poor myocardial perfusion, and
higher MPV also indicates worse left ventricular systolic function post
PPCI.
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A new cooperative approach in treatment of acute myocardial
infarction in China
Jinchuan Yan
Afﬁliated Hospital of Jiangsu University
OBJECTIVES Acute myocardial infarction (AMI) is the most serious
type of coronary heart disease that affect the life and health of people,
but < 30% of all of the patients with AMI have been treated effectively
and timely in China. Delayed treatment has been considered as a
leading cause of death and severe outcomes. This study aimed to
evaluate a new regional cooperative emergency model in improving
the ﬁrst medical contact-to-balloon time and the therapeutic effects
on patients with ST-elevation myocardial infarction (STEMI).
METHODS A new regional cooperative emergency model was estab-
lished in some regions of Zhenjiang, Jiangsu province in China. A
retrospective analysis of 458 STEMI patients before and after the
model used in these regions was performed. Patients were divided
into two groups in terms of before or after the regional cooperative
rescue model used: model group (n¼285) and control group (n¼173).
The ﬁrst medical contact-to-balloon (FMC-to-B) time, door-to-balloon
(D-to-B) time, referral time, cardiac function, mean cost, days of
hospitalization, and major adverse cardiac events (MACE) were
analyzed.
RESULTS The mean FMC-to-B time, D-to-B time and referral time of
the model group were 97  20, 22  8, 61  17 min, respectively, these
parameters were signiﬁcantly lower than the corresponding indexes
of the control group (211  27, 105  14, 101  19 min). Six months after
the patients were discharged from the hospital, the left ventricular
ejection fraction (LVEF) of the model group increased but left ven-
tricular end-diastolic dimension (LVED) was decreased when
compared with control group. These results also showed that mean
costs (43813.0  2731.0 vs 50471.0  5264.0 CNY) and days of hospi-
talization (7.85  3.15 vs 11.02  4.06 days) were reduced. The inci-
dence rate of MACE in the model group was 8.2%, which was lower
than the rate of 16.8% in the control group.
CONCLUSIONS Regional cooperative emergency model may decrease
the FMC-to-B time, which could improve the cardiac function, ther-
apeutic effect on patients with AMI, and decrease ﬁnancial burden of
patients.
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Platelet aggregation inﬂuenced by the loading-dose of multiple
anti-platelet therapy in patients with acute myocardial infarction
Long Peng,1 Xixiang Tang,2 Yanting Luo,1 Jinlai Liu1
1Department of Cardiology, the Third Afﬁliated Hospital, Sun Yat-sen
University; 2Advanced Center, the Third Afﬁliated Hospital, Sun
Yat-sen University
OBJECTIVES Due to the severity of acute myocardial infarction (AMI)
and cardiovascular interventions, many patients should be prescribed
multiple anti-platelet therapy to reduce platelet aggregation. We
aimed to explore the inﬂuence of the loading-dose of multiple
anti-platelet drugs on the inhibition of platelet aggregation in patients
with AMI.
METHODS The present study included 84 patients who were initially
diagnosed with AMI. Patients were divided into 3 groups randomly:AC group (aspirin 0.3g plus clopidogrel 0.3g), ATG group (aspirins 0.3g
plus ticagrelor 0.18g), and ACTF group (triple therapy with aspirins
0.3g, clopidogrel 0.3g and tiroﬁban 0.15ug/kg/min). Adenosine
diphosphate(ADP)-induced platelet aggregation was measured using
the multiplate analyzer at the time of initial diagnose of AMI, 2 hours
after taking loading-dose of anti-platelet therapy, and the second
morning.
RESULTS There were no signiﬁcant differences in demographic
characteristics among groups, including age, risk factors and sex. In
the ADP-induced platelet aggregation ratio, there were not statisti-
cally signiﬁcant among groups at the time of initial diagnose of AMI.
However, there was signiﬁcant difference between before and after
the administration of anti-platelet drugs (53.3%11.2% vs 27.9%
8.5%, p<0.05) in all patients. The platelet aggregation ratio of triple
therapy groups was signiﬁcantly lower than dual anti-platelet ther-
apy, both at the time of 2h after administration drugs and the second
morning(14.3%6.3% vs 23.5%9.4%, p<0.05; 16.4%8.5% vs 33.5%
9.4%). Compared with AC group, ATG group had a signiﬁcantly lower
platelet aggregation ratio at the time of 2 hours after administer drugs
(26.4%7.8% vs 20.6%4.5%, p<0.05). There were no signiﬁcant
differences between AC group and ATG group at the second morning
(32.5%6.4% vs 34.5%7.3%, p¼0.3).
CONCLUSIONS Addition tiroﬁban to conventional dual anti-platelet
therapy can reduce drastically platelet aggregation ratio for the pa-
tients with AMI. Compared to aspirin combination with clopidogrel,
aspirin plus ticagrelor had better inhibiting effect in 2 hours after
administration.
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Peripheral blood based discrimination of Coronary Heart Disease from
healthy people by genome-wide gene expression proﬁling in
Chinese Han people
Lin Fan,1 Heyu Meng,2 Fanbo Meng1
1Department of Cardiology, China–Japan Union Hospital, Jilin
University, Changchun, China; 2Yanbian University Medical College,
Yanji, China
OBJECTIVES The polygenic inheritance and the dependence on
environmental factors pose a challenge for the diagnosis and treat-
ment of coronary heart disease (CHD). We hypothesized that a mo-
lecular diagnostic assay using easily accessible peripheral blood
would greatly assist in the screening and diagnosis of CHD. In order to
validate this a microarray analysis was carried out, the results indi-
cated that there were some genes had differential expression. We
discussed the function of these differential genes in the process of the
occurrence and development of CHD and further evaluated their
diagnostic potential in CHD.
METHODS A total of 26 subjects (n¼26) were recruited in this study
including 13 CHD and 13 healthy people. The total mRNA of the sub-
jects were isolated from leukocyte in the peripheral blood within 4
hours after collection, and were reversed-transcribed to cDNAs as
soon as possible. We constructed 2 pools of 3 subjects (3 CHD and 3
healthy people) for microarray screening with Affymetrix GeneChip
Scanner 3000 to discover new biomarkers and candidate genes. The
results were analyzed with SAM, GO, KEGG. The other samples were
used for RT-PCR to conﬁrm the microarray on the next step.
Randomly selected three candidate genes from the results of micro-
array for RT-PCR: CYP4F3 acted as up-regulated group, IL13RA1 acted
as normal expression group, MED6 acted as down-regulated group.
The results of RT-PCR was analyzed by 2-DDCt method.
RESULTS The results of microarray were analyzed by Affymetrix
Expression Console Software. With the choice criterion of p0.05,
logFC1 or logFC-1, there were 300 differential genes being selected,
among them 30 genes had over expression and 270 genes had low
expression. Analyzed by GO showed these 300 genes belonged to 105
cellular components, and involved in 295 biological processes and
participated in the regulation of 212 molecular functions. Analyzed by
KEGG showed that these genes took part in 75 gene pathways. The results
of RT-PCR analyzed with 2-DDCt method showed that compared to healthy
people, the expression of CYP4F3 gene was 2.06  0.57 (p¼0.004), the
expression of IL13RA1 gene was 0.96 0.05 (p¼0.870), and the expression
of MED6 gene was 0.62  0.12 (p¼0.002). All the results obtained from
RT-PCR were in accordance with the results of microarray.
CONCLUSIONS The microarray can be used as the foundation of
exploring the pathogenic gene for coronary heart disease, and the
differential expression of CYP4F3 or MED6 may take effect on the
process of the occurrence and development of coronary heart disease.
It can be conjectured that these ﬁndings may serve to identify new
